Cybersecurity’s Role in Biotech Valuation & Funding
For biotech executives preparing for funding rounds or strategic partnerships, cybersecurity has quietly moved from a technical issue to a valuation issue. Investors increasingly evaluate operational risk when assessing the stability of a biotech firm. Intellectual property, proprietary research, clinical data, and patient information represent enormous economic value and they are also prime targets for […]